IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 70 filers reported holding IRADIMED CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,547,237 | +8.0% | 57,971 | +8.1% | 0.00% | – |
Q1 2024 | $2,358,221 | -11.3% | 53,608 | -4.3% | 0.00% | -100.0% |
Q4 2023 | $2,659,792 | +7.9% | 56,031 | +0.9% | 0.00% | 0.0% |
Q3 2023 | $2,464,309 | -4.7% | 55,540 | +2.6% | 0.00% | 0.0% |
Q2 2023 | $2,585,169 | +23.9% | 54,151 | +2.2% | 0.00% | – |
Q1 2023 | $2,085,747 | +35.2% | 53,005 | -2.8% | 0.00% | – |
Q4 2022 | $1,542,569 | -8.3% | 54,527 | -2.6% | 0.00% | – |
Q3 2022 | $1,683,000 | -8.0% | 55,999 | +3.9% | 0.00% | – |
Q2 2022 | $1,829,000 | -24.0% | 53,875 | +0.4% | 0.00% | – |
Q1 2022 | $2,408,000 | -14.9% | 53,684 | -12.4% | 0.00% | -100.0% |
Q4 2021 | $2,831,000 | +37.9% | 61,265 | +0.3% | 0.00% | – |
Q3 2021 | $2,053,000 | +18.5% | 61,100 | +3.7% | 0.00% | – |
Q2 2021 | $1,733,000 | +13.9% | 58,928 | -0.1% | 0.00% | – |
Q1 2021 | $1,521,000 | +12.8% | 59,004 | -0.2% | 0.00% | – |
Q4 2020 | $1,348,000 | +12.6% | 59,129 | +5.5% | 0.00% | – |
Q3 2020 | $1,197,000 | -8.4% | 56,032 | -0.5% | 0.00% | – |
Q2 2020 | $1,307,000 | +11.1% | 56,305 | +2.2% | 0.00% | – |
Q1 2020 | $1,176,000 | -10.0% | 55,069 | -1.5% | 0.00% | – |
Q4 2019 | $1,307,000 | +19.5% | 55,892 | +7.4% | 0.00% | – |
Q3 2019 | $1,094,000 | +10.4% | 52,023 | +7.3% | 0.00% | – |
Q2 2019 | $991,000 | -3.6% | 48,491 | +32.5% | 0.00% | – |
Q1 2019 | $1,028,000 | +26.4% | 36,603 | +10.1% | 0.00% | – |
Q4 2018 | $813,000 | -28.8% | 33,252 | +8.1% | 0.00% | – |
Q3 2018 | $1,142,000 | +143.5% | 30,749 | +36.1% | 0.00% | – |
Q2 2018 | $469,000 | +111.3% | 22,588 | +46.4% | 0.00% | – |
Q1 2018 | $222,000 | -5.1% | 15,432 | 0.0% | 0.00% | – |
Q4 2017 | $234,000 | +58.1% | 15,432 | 0.0% | 0.00% | – |
Q3 2017 | $148,000 | +11.3% | 15,432 | 0.0% | 0.00% | – |
Q2 2017 | $133,000 | -36.7% | 15,432 | -34.8% | 0.00% | – |
Q1 2017 | $210,000 | -42.8% | 23,661 | -28.5% | 0.00% | – |
Q4 2016 | $367,000 | -27.6% | 33,094 | +10.9% | 0.00% | – |
Q3 2016 | $507,000 | +5.6% | 29,837 | +35.2% | 0.00% | – |
Q2 2016 | $480,000 | +62.2% | 22,065 | +42.9% | 0.00% | – |
Q1 2016 | $296,000 | +8.8% | 15,439 | +58.6% | 0.00% | – |
Q4 2015 | $272,000 | +27.1% | 9,734 | +10.6% | 0.00% | – |
Q3 2015 | $214,000 | – | 8,802 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 234,810 | $5,013,000 | 5.83% |
Nine Ten Capital Management LLC | 277,088 | $5,916,000 | 2.51% |
RK Capital | 211,325 | $4,512,000 | 2.03% |
Parkman Healthcare Partners LLC | 113,855 | $2,431,000 | 1.13% |
Ranger Investment Management | 235,312 | $5,024,000 | 0.44% |
CADENCE CAPITAL MANAGEMENT LLC | 101,720 | $2,172,000 | 0.37% |
ALGERT GLOBAL LLC | 30,152 | $644,000 | 0.27% |
Mondrian Investment Partners LTD | 163,939 | $3,500,000 | 0.12% |
NAVELLIER & ASSOCIATES INC | 20,800 | $444,000 | 0.10% |
GLOBEFLEX CAPITAL L P | 15,510 | $331,000 | 0.10% |